特发性肺纤维化的呼吸症状管理——当前证据
IPF Respiratory Symptoms Management - Current Evidence.
作者信息
Janowiak Piotr, Szymanowska-Narloch Amelia, Siemińska Alicja
机构信息
Department of Pulmonology, Medical University of Gdańsk, Gdańsk, Poland.
出版信息
Front Med (Lausanne). 2022 Jul 28;9:917973. doi: 10.3389/fmed.2022.917973. eCollection 2022.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a progressive, chronic disease of the lungs which is characterized by heavy symptom burden, especially in the last year of life. Despite recently established anti-fibrotic treatment IPF prognosis is one of the worst among interstitial lung diseases. In this review available evidence regarding pharmacological and non-pharmacological management of the main IPF symptoms, dyspnea and cough, is presented.
摘要
特发性肺纤维化（IPF）是一种进行性的慢性肺部疾病，其特征是症状负担沉重，尤其是在生命的最后一年。尽管最近确立了抗纤维化治疗方法，但IPF的预后在间质性肺病中是最差的之一。在这篇综述中，我们介绍了有关IPF主要症状（呼吸困难和咳嗽）的药物和非药物管理的现有证据。
相似文献
1
IPF Respiratory Symptoms Management - Current Evidence.特发性肺纤维化的呼吸症状管理——当前证据
Front Med (Lausanne). 2022 Jul 28;9:917973. doi: 10.3389/fmed.2022.917973. eCollection 2022.
2
Management of musculoskeletal pain in patients with idiopathic pulmonary fibrosis: a review.特发性肺纤维化患者肌肉骨骼疼痛的管理：综述。
Ups J Med Sci. 2022 Jul 11;127. doi: 10.48101/ujms.v127.8739. eCollection 2022.
3
High-flow nasal cannula (HFNC) vs continuous positive airway pressure (CPAP) vs nasal intermittent positive pressure ventilation as primary respiratory support in infants of ≥ 32 weeks gestational age (GA): study protocol for a three-arm multi-center randomized controlled trial.高流量鼻导管（HFNC）与持续气道正压通气（CPAP）及鼻间歇正压通气作为孕龄≥32周婴儿主要呼吸支持的比较：一项三臂多中心随机对照试验的研究方案
Trials. 2023 Oct 6;24(1):647. doi: 10.1186/s13063-023-07665-7.
4
High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multicenter, randomized controlled trial.高流量鼻导管氧疗与无创通气在 COPD 患者拔管后应用的比较：一项多中心、随机对照试验。
Crit Care. 2020 Aug 6;24(1):489. doi: 10.1186/s13054-020-03214-9.
5
High-flow nasal cannula oxygen therapy to treat acute respiratory failure in patients with acute exacerbation of idiopathic pulmonary fibrosis.高流量鼻导管氧疗治疗特发性肺纤维化急性加重期患者的急性呼吸衰竭。
Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619847130. doi: 10.1177/1753466619847130.
6
[Comparative study on pros and cons of sequential high-flow nasal cannula and non-invasive positive pressure ventilation immediately following early extubated patients with severe respiratory failure due to acute exacerbations of chronic obstructive pulmonary disease].[慢性阻塞性肺疾病急性加重致严重呼吸衰竭早期拔管患者序贯高流量鼻导管与无创正压通气利弊的对比研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Oct;33(10):1215-1220. doi: 10.3760/cma.j.cn121430-20210623-00939.
7
High-flow nasal cannula oxygen therapy in idiopathic pulmonary fibrosis patients with respiratory failure.高流量鼻导管给氧疗法用于治疗患有呼吸衰竭的特发性肺纤维化患者。
J Thorac Dis. 2020 Mar;12(3):966-972. doi: 10.21037/jtd.2019.12.48.
8
The burden of cough in idiopathic pulmonary fibrosis and other interstitial lung diseases: a systematic evidence synthesis.特发性肺纤维化和其他间质性肺疾病咳嗽负担：系统证据综合。
Respir Res. 2024 Aug 27;25(1):325. doi: 10.1186/s12931-024-02897-w.
9
High flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease with acute-moderate hypercapnic respiratory failure: an observational cohort study.高流量鼻导管氧疗与无创通气治疗慢性阻塞性肺疾病合并急性中度高碳酸血症呼吸衰竭的比较：一项观察性队列研究。
Int J Chron Obstruct Pulmon Dis. 2019 Jun 5;14:1229-1237. doi: 10.2147/COPD.S206567. eCollection 2019.
10
A Review on Non-invasive Respiratory Support for Management of Respiratory Distress in Extremely Preterm Infants.极早产儿呼吸窘迫管理的无创呼吸支持综述
Front Pediatr. 2020 May 28;8:270. doi: 10.3389/fped.2020.00270. eCollection 2020.
引用本文的文献
1
Advances and frontiers in pulmonary fibrosis and lung cancer research (2000-2024): a bibliometric analysis.肺纤维化与肺癌研究的进展与前沿（2000 - 2024）：文献计量分析
Front Med (Lausanne). 2025 Jun 23;12:1596228. doi: 10.3389/fmed.2025.1596228. eCollection 2025.
2
Pulmonary fibroblast-specific delivery of siRNA exploiting exosomes-based nanoscaffolds for IPF treatment.利用基于外泌体的纳米支架实现对肺成纤维细胞的特异性小干扰RNA递送用于特发性肺纤维化治疗。
Asian J Pharm Sci. 2024 Aug;19(4):100929. doi: 10.1016/j.ajps.2024.100929. Epub 2024 Jun 11.
3
Lung cell transplantation for pulmonary fibrosis.肺纤维化的肺细胞移植。
Sci Adv. 2024 Aug 23;10(34):eadk2524. doi: 10.1126/sciadv.adk2524.
4
Respiratory diseases and gut microbiota: relevance, pathogenesis, and treatment.呼吸系统疾病与肠道微生物群：相关性、发病机制及治疗
Front Microbiol. 2024 Jul 16;15:1358597. doi: 10.3389/fmicb.2024.1358597. eCollection 2024.
5
Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant.吡非尼酮治疗特发性肺纤维化：疗效与安全性的真实世界观察，重点关注接受抗血栓和抗凝治疗的患者
Pharmaceuticals (Basel). 2024 Jul 11;17(7):930. doi: 10.3390/ph17070930.
6
Pharmacological treatment in Idiopathic Pulmonary Fibrosis: current issues and future perspectives.特发性肺纤维化的药物治疗：当前问题与未来展望
Multidiscip Respir Med. 2024 Jun 13;19(1):982. doi: 10.5826/mrm.2024.982.
7
Cardiovascular Structural and Functional Parameters in Idiopathic Pulmonary Fibrosis at Disease Diagnosis.特发性肺纤维化发病时的心血管结构和功能参数。
High Blood Press Cardiovasc Prev. 2024 May;31(3):289-297. doi: 10.1007/s40292-024-00638-0. Epub 2024 May 13.
8
Improvement of idiopathic pulmonary fibrosis through a combination of radix and radix via mammalian target of rapamycin signaling pathway-induced autophagy in rat.通过雷帕霉素靶蛋白信号通路诱导自噬，黄芪与丹参联合用药改善大鼠特发性肺纤维化
J Thorac Dis. 2024 Feb 29;16(2):1397-1411. doi: 10.21037/jtd-24-28. Epub 2024 Feb 27.
9
The interplay of physical and cognitive function in rehabilitation of interstitial lung disease patients: a narrative review.间质性肺疾病患者康复中身体与认知功能的相互作用：一项叙述性综述
J Thorac Dis. 2023 Aug 31;15(8):4503-4521. doi: 10.21037/jtd-23-209. Epub 2023 Jul 24.
10
Genes related to N6-methyladenosine in the diagnosis and prognosis of idiopathic pulmonary fibrosis.与N6-甲基腺苷相关的基因在特发性肺纤维化诊断和预后中的作用
Front Genet. 2023 Jan 4;13:1102422. doi: 10.3389/fgene.2022.1102422. eCollection 2022.
本文引用的文献
1
Impact of high-flow oxygen therapy during exercise in idiopathic pulmonary fibrosis: a pilot crossover clinical trial.特发性肺纤维化运动中高流量氧疗的影响：一项初步的交叉临床试验。
BMC Pulm Med. 2021 Nov 8;21(1):355. doi: 10.1186/s12890-021-01727-9.
2
Effect of high-flow nasal cannula oxygen therapy on exercise tolerance in patients with idiopathic pulmonary fibrosis: A randomized crossover trial.高流量鼻导管吸氧疗法对特发性肺纤维化患者运动耐力的影响：一项随机交叉试验。
Respirology. 2022 Feb;27(2):144-151. doi: 10.1111/resp.14176. Epub 2021 Nov 2.
3
Pulmonary rehabilitation for interstitial lung disease.间质性肺疾病的肺康复治疗。
Cochrane Database Syst Rev. 2021 Feb 1;2(2):CD006322. doi: 10.1002/14651858.CD006322.pub4.
4
The effect of heated humidified nasal high flow oxygen supply on exercise tolerance in patients with interstitial lung disease: A pilot study.加温湿化经鼻高流量给氧对间质性肺疾病患者运动耐力的影响：一项初步研究。
Respir Med. 2021 Sep;186:106523. doi: 10.1016/j.rmed.2021.106523. Epub 2021 Jun 29.
5
Managing Cough in Idiopathic Pulmonary Fibrosis.特发性肺纤维化咳嗽的管理。
Chest. 2021 Nov;160(5):1774-1782. doi: 10.1016/j.chest.2021.05.071. Epub 2021 Jun 23.
6
Oxygen supplementation during exercise improves leg muscle fatigue in chronic fibrotic interstitial lung disease.运动时补充氧气可改善慢性纤维化间质性肺疾病患者的腿部肌肉疲劳。
Thorax. 2021 Jul;76(7):672-680. doi: 10.1136/thoraxjnl-2020-215135. Epub 2021 Feb 4.
7
End-of-life home care of an interstitial pneumonia patient supported by high-flow nasal cannula therapy: A case report.高流量鼻导管治疗支持的间质性肺炎患者的临终居家护理：一例报告
World J Clin Cases. 2020 Oct 26;8(20):4853-4857. doi: 10.12998/wjcc.v8.i20.4853.
8
Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline.慢性肺部疾病成人家庭氧疗。美国胸科学会临床实践指南。
Am J Respir Crit Care Med. 2020 Nov 15;202(10):e121-e141. doi: 10.1164/rccm.202009-3608ST.
9
Cardiopulmonary Exercise Testing in Patients With Interstitial Lung Disease.间质性肺疾病患者的心肺运动试验
Front Physiol. 2020 Jul 10;11:832. doi: 10.3389/fphys.2020.00832. eCollection 2020.
10
Supplemental oxygen improves exercise capacity in IPF patients with exertional desaturation.补充氧气可改善有运动性低氧血症的特发性肺纤维化患者的运动能力。
Respirology. 2020 Nov;25(11):1152-1159. doi: 10.1111/resp.13829. Epub 2020 May 5.
Zotero 插件